The chemical substance known as "(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-ylhydrogensulfate" with CAS number 1467829-71-5 is a complex organic compound characterized by its bicyclic structure, which includes a diazabicyclo framework. This compound features a carbamoyl group, contributing to its potential biological activity, and a sulfonate group, which enhances its solubility in polar solvents. The presence of a ketone functional group (7-oxo) indicates potential reactivity, while the stereochemistry denoted by (2S,5R) suggests specific spatial arrangements of atoms that can influence its interaction with biological targets. Such compounds may exhibit pharmacological properties, making them of interest in medicinal chemistry. The unique structural features, including the bicyclic system and functional groups, suggest that this compound could participate in various chemical reactions, potentially serving as a precursor or active ingredient in drug development. Further studies would be necessary to elucidate its specific properties, reactivity, and potential applications in various fields, including pharmaceuticals and biochemistry.

Durlobactam is a beta-lactamase inhibitor used in combination with sulbactam to treat susceptible strains of bacteria in the genus Acinetobacter. It is an analog of avibactam.

(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-ylhydrogensulfate

1467829-71-5: The chemical substance known as "(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-ylhydrogensulfate" with CAS number 1467829-71-5 is a complex organic compound characterized by its bicyclic structure, which includes a diazabicyclo framework. This compound features a carbamoyl group, contributing to its potential biological activity, and a sulfonate group, which enhances its solubility in polar solvents. The presence of a ketone functional group (7-oxo) indicates potential reactivity, while the stereochemistry denoted by (2S,5R) suggests specific spatial arrangements of atoms that can influence its interaction with biological targets. Such compounds may exhibit pharmacological properties, making them of interest in medicinal chemistry. The unique structural features, including the bicyclic system and functional groups, suggest that this compound could participate in various chemical reactions, potentially serving as a precursor or active ingredient in drug development. Further studies would be necessary to elucidate its specific properties, reactivity, and potential applications in various fields, including pharmaceuticals and biochemistry.

<p>Durlobactam is a drug candidate for beta-lactamase inhibitor.</p>

CAS 1467829-71-5

(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-ylhydrogensulfate

Durlobactam

Ref: TM-T25355